The public record · 119th Congress

Prescription Drug Supply Chain Pricing Transparency Act

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

A bill to require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.Official Title as Introduced

Prescription Drug Supply Chain Pricing Transparency ActShort Title(s) as Introduced

Legislative history

S. 3751·Senate·Bill·Health

Sen. Michael F. Bennet(Democratic-Colorado)·

Jan 29, 2026

SenateRead twice and referred to the Committee on Finance.

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

Jan 29, 2026As introduced in the Senate